A detailed history of Newman Dignan & Sheerar, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 868 shares of BDX stock, worth $198,329. This represents 0.04% of its overall portfolio holdings.

Number of Shares
868
Previous 968 10.33%
Holding current value
$198,329
Previous $226,000 7.52%
% of portfolio
0.04%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$221.47 - $242.41 $22,147 - $24,241
-100 Reduced 10.33%
868 $209,000
Q2 2024

Jul 15, 2024

SELL
$225.07 - $246.17 $1,575 - $1,723
-7 Reduced 0.72%
968 $226,000
Q1 2024

Apr 26, 2024

SELL
$233.45 - $247.73 $233 - $247
-1 Reduced 0.1%
975 $241,000
Q4 2023

Feb 08, 2024

BUY
$232.24 - $267.23 $232 - $267
1 Added 0.1%
976 $237,000
Q3 2023

Nov 07, 2023

BUY
$254.9 - $283.59 $1,784 - $1,985
7 Added 0.72%
975 $252,000
Q3 2022

Oct 18, 2022

SELL
$51.03 - $264.23 $3,061 - $15,853
-60 Reduced 5.84%
968 $216,000
Q2 2021

Jul 28, 2021

SELL
$232.65 - $254.58 $18,612 - $20,366
-80 Reduced 7.22%
1,028 $250,000
Q4 2020

Jan 29, 2021

BUY
$221.92 - $245.94 $17,753 - $19,675
80 Added 7.78%
1,108 $277,000
Q2 2020

Aug 06, 2020

BUY
$219.9 - $263.41 $14,953 - $17,911
68 Added 7.08%
1,028 $282,000
Q1 2020

Apr 20, 2020

SELL
$195.69 - $279.01 $53,814 - $76,727
-275 Reduced 22.27%
960 $242,000
Q2 2019

Jul 31, 2019

BUY
$217.4 - $246.08 $4,348 - $4,921
20 Added 1.65%
1,235 $311,000
Q4 2017

Jan 29, 2018

SELL
$189.0 - $222.64 $11,340 - $13,358
-60 Reduced 4.71%
1,215 $260,000
Q2 2017

Aug 08, 2017

BUY
N/A
1,275
1,275 $249,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Newman Dignan & Sheerar, Inc. Portfolio

Follow Newman Dignan & Sheerar, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.